BackSynaptogenix Overview

Synaptogenix Current Cash

Synaptogenix's current cash is $3.6M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$3.65M
75.42% YoYΔ $-11.19M vs prior year quarter

Peer average

Loading

Synaptogenix Current Cash History

Loading

Synaptogenix vs. peers: Current Cash Comparison

Loading

Synaptogenix Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Synaptogenix (SNPX) FAQ

The latest current cash for SNPX is $3.6M as of March 2026. That compares with $15M in the prior-year period — down 75.4% year over year. Investors often review this figure alongside Synaptogenix's historical trend and sector peers before judging valuation or financial health.

Over the past year, SNPX's current cash moved from $15M to $3.6M — a 75.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Synaptogenix's operating scale or balance-sheet position.

A current cash figure of $3.6M for SNPX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SNPX's current cash ($3.6M), review year-over-year change from $15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Synaptogenix's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.